Barnes & Noble

Tuesday, December 18, 2012

Avon Foundation for Women Awards



2012 marks the 20th anniversary of Avon’s Breast Cancer Crusade. Over the last two decades, Avon global philanthropy in 58 countries has donated more than $780 million to organizations around the world to accelerate breast cancer research and improve access to breast health care for all women.

Our Oct. 30, 2012, Avon Foundation for Women Awards Gala was planned to celebrate the important achievements that our support has made possible. But, our 12th annual Gala was canceled for the first time ever, as Hurricane Sandy stormed through New York City. So we want to take this opportunity to recognize the leadership of some extraordinary doctors, scientists, and advocates whom we’ve had the honor to support. Watch the videos and read more below to celebrate the 2012 Avon honorees, whose work is leading the way toward eradicating breast cancer:

                                                       






About the Avon Breast Cancer Crusade 

The Avon Breast Cancer Crusade, which commemorates its 20th anniversary in 2012, has placed Avon at the forefront of the fight against breast cancer; today, Avon is the leading corporate supporter of the cause globally. In the 20 years since the Crusade's launch, Avon breast cancer programs in 58 countries have donated more than $740 million for research and advancing access to care, regardless of a person's ability to pay. Avon awards funding to beneficiaries ranging from leading cancer centers to community-based grassroots breast health programs to support breast cancer research and access to care. The Crusade has enabled more than 17 million women globally to receive free mammograms and breast cancer screenings, educated more than 100 million women about breast cancer, and funded promising research into the causes of breast cancer and ways to prevent the disease. Avon raises funds for the Crusade through the sale of Avon "Pink Ribbon" products, and through events such as the U.S. Avon Walk for Breast Cancer series, which is the Foundation's largest fund-raising source. 

No comments:

Post a Comment